panCELLa is developing therapeutic tools applied to a therapeutic cell line that is modified to provide a high level of safety before and after the cells are introduced to the patient. FailSafe acts as a safety switch: the suicide gene is activated by a pro-drug to shut down only the cells that are deregulating while allowing the therapeutic cells to continue to function and treat the patient.